Use the Back button in your browser to see the other results of your search or to select another record.

Detailed Search Results

Does robot-assisted gait training improve ambulation in highly disabled multiple sclerosis people? A pilot randomized control trial [with consumer summary]
Pompa A, Morone G, Iosa M, Pace L, Catani S, Casillo P, Clemenzi A, Troisi E, Tonini A, Paolucci S, Grasso MG
Multiple Sclerosis Journal 2017 Apr;23(5):696-703
clinical trial
8/10 [Eligibility criteria: Yes; Random allocation: Yes; Concealed allocation: Yes; Baseline comparability: Yes; Blind subjects: No; Blind therapists: No; Blind assessors: Yes; Adequate follow-up: Yes; Intention-to-treat analysis: Yes; Between-group comparisons: Yes; Point estimates and variability: Yes. Note: Eligibility criteria item does not contribute to total score] *This score has been confirmed*

BACKGROUND: Robotic training is commonly used to assist walking training in patients affected by multiple sclerosis (MS) with non-conclusive results. OBJECTIVE: To compare the effect of robot-assisted gait training (RAGT) with that of conventional walking training (CWT) on gait competencies, global ability, fatigue and spasticity in a group of severely affected patients with MS. METHODS: A pilot, single-blind randomized controlled trial was conducted in 43 severe (Expanded Disability Status Scale (EDSS) score of 6 to 7.5) and non-autonomous ambulant in-patients with MS. Experimental group performed 12 sessions of RAGT, whereas control group performed the same amount of CWT. Primary outcome measures were gait ability assessed by 2 minutes walking test and Functional Ambulatory Category; secondary outcomes were global ability (modified Barthel Index), global mobility (Rivermead Mobility Index), severity of disease (EDSS) and subjectively perceived fatigue (Fatigue Severity Scale). RESULTS: The number of subjects who achieved a clinical significant improvement was significantly higher in RAGT than in CWT (p < 0.05 for both primary outcome measures). RAGT also led to an improvement in all the other clinical parameters (global ability p < 0.001, global mobility p < 0.001, EDSS p = 0.014 and fatigue p = 0.001). CONCLUSIONS: RAGT improved the walking competencies in non-autonomous ambulant patients with MS, with benefits in terms of perceived fatigue.

Full text (sometimes free) may be available at these link(s):      help